HARA, Yoshimi et al. Clinical Utility of Targeted Next-Generation Sequencing for Determining Human Epidermal Growth Factor Receptor 2 Status and Optimizing Targeted Therapy in Breast Cancer. World Journal of Oncology, [S. l.], v. 16, n. 4, p. 347–356, 2025. DOI: 10.14740/wjon2583. Disponível em: https://wjon.elmerpub.com/wjon/article/view/2583.. Acesso em: 26 aug. 2025.